Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-Current Assets (2020 - 2025)

Journey Medical's Non-Current Assets history spans 6 years, with the latest figure at $27.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Assets fell 13.55% year-over-year to $27.7 million, compared with a TTM value of $117.4 million through Dec 2025, up 33.06%, and an annual FY2025 reading of $27.7 million, down 13.55% over the prior year.
  • Non-Current Assets for Q4 2025 was $27.7 million at Journey Medical, down from $28.8 million in the prior quarter.
  • The five-year high for Non-Current Assets was $35.1 million in Q1 2023, with the low at $12.8 million in Q4 2021.
  • Average Non-Current Assets over 5 years is $25.3 million, with a median of $27.6 million recorded in 2022.
  • Year-over-year, Non-Current Assets surged 114.85% in 2022 and then tumbled 44.33% in 2024.
  • Tracing DERM's Non-Current Assets over 5 years: stood at $12.8 million in 2021, then skyrocketed by 114.85% to $27.5 million in 2022, then dropped by 25.79% to $20.4 million in 2023, then soared by 57.21% to $32.1 million in 2024, then fell by 13.55% to $27.7 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Non-Current Assets are $27.7 million (Q4 2025), $28.8 million (Q3 2025), and $29.9 million (Q2 2025).